Zynerba Pharmaceuticals Announces Poster Presentations at the 55th Gatlinburg Conference
DEVON, Pa., April 05, 2023 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader…
Month: April 2023
Generation Bio Appoints Yalonda Howze, J.D. as Chief Legal Officer
CAMBRIDGE, Mass., April 05, 2023 (GLOBE NEWSWIRE) — Generation Bio Co. (Nasdaq:GBIO), a biotechnology company…
Generation Bio Appoints Yalonda Howze, J.D. as Chief Legal Officer
CAMBRIDGE, Mass., April 05, 2023 (GLOBE NEWSWIRE) — Generation Bio Co. (Nasdaq:GBIO), a biotechnology company…
Endogena Therapeutics Completes Dose Escalation in the Phase 1/2a Clinical Trial of EA-2353 for the Treatment of Retinitis Pigmentosa
SAN FRANCISCO and TORONTO and ZÜRICH, Switzerland, April 05, 2023 (GLOBE NEWSWIRE) — Endogena Therapeutics…
Endogena Therapeutics Completes Dose Escalation in the Phase 1/2a Clinical Trial of EA-2353 for the Treatment of Retinitis Pigmentosa
SAN FRANCISCO and TORONTO and ZÜRICH, Switzerland, April 05, 2023 (GLOBE NEWSWIRE) — Endogena Therapeutics…
Kraig Biocraft Laboratories Preparing Response to U.S. Department of Defense Request for Information on Domestic Biomanufacturing of Spider Silk
ANN ARBOR, Mich., April 05, 2023 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB)…
Kraig Biocraft Laboratories Preparing Response to U.S. Department of Defense Request for Information on Domestic Biomanufacturing of Spider Silk
ANN ARBOR, Mich., April 05, 2023 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB)…
Clearside Biomedical Enhances Scientific Advisory Board with the Appointment of Two Distinguished Retinal Physicians
ALPHARETTA, Ga., April 05, 2023 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing…
Clearside Biomedical Enhances Scientific Advisory Board with the Appointment of Two Distinguished Retinal Physicians
ALPHARETTA, Ga., April 05, 2023 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing…
Societal CDMO Selected by Longboard Pharmaceuticals to Provide CDMO Services to Support Clinical Development of LP352
CDMO Services Focused on Longboard’s Oral, Centrally Acting 5-HT2C Receptor Superagonist, Being Developed for the…
Societal CDMO Selected by Longboard Pharmaceuticals to Provide CDMO Services to Support Clinical Development of LP352
CDMO Services Focused on Longboard’s Oral, Centrally Acting 5-HT2C Receptor Superagonist, Being Developed for the…
SparingVision appoints Joseph C. Papa as Chairman
SparingVision appoints Joseph C. Papa as Chairman Former Bausch and Lomb Chairman and CEO joins…
SparingVision appoints Joseph C. Papa as Chairman
SparingVision appoints Joseph C. Papa as Chairman Former Bausch and Lomb Chairman and CEO joins…
Tonix Pharmaceuticals Announces Poster Presentations at the American Association for Cancer Research Annual Meeting 2023
Data from Animal Studies on TNX-1700 (recombinant TFF2 – albumin fusion peptide) in Syngeneic Models…
Tonix Pharmaceuticals Announces Poster Presentations at the American Association for Cancer Research Annual Meeting 2023
Data from Animal Studies on TNX-1700 (recombinant TFF2 – albumin fusion peptide) in Syngeneic Models…
Proxygen Announces Collaboration and License Agreement with MSD for the Discovery and Development of Novel Molecular Glue Degraders
VIENNA, Austria, April 05, 2023 (GLOBE NEWSWIRE) — Proxygen, a leader in the discovery and…
Proxygen Announces Collaboration and License Agreement with MSD for the Discovery and Development of Novel Molecular Glue Degraders
VIENNA, Austria, April 05, 2023 (GLOBE NEWSWIRE) — Proxygen, a leader in the discovery and…
AC Immune to Host Key Opinion Leader Webinar on Early Diagnosis and Prevention of Alzheimer’s Disease
AC Immune to Host Key Opinion Leader Webinar on Early Diagnosis and Prevention of Alzheimer’s…
AC Immune to Host Key Opinion Leader Webinar on Early Diagnosis and Prevention of Alzheimer’s Disease
AC Immune to Host Key Opinion Leader Webinar on Early Diagnosis and Prevention of Alzheimer’s…
Oculis to Participate at Upcoming Investor Conferences
ZUG, Switzerland and BOSTON, April 05, 2023 (GLOBE NEWSWIRE) — Oculis Holding AG (Nasdaq: OCS)…